Teenagers who interact with cannabis brands via social media platforms are five times more likely to consume cannabis to those who don’t, according to a new study conducted by researchers with the University of Wisconsin School of Medicine and Public Health.
This study is said to be the first in the U.S. to research the impact marijuana advertising on social media has on cannabis consumption among youth, Green Rush Daily reported.
One in three teens who live in states where recreational cannabis has been legalized interact with cannabis brands on social media platforms, the study found.
The research surveyed 482 teens between 15-19 living in six states where cannabis consumption is legal.
Thirty-three percent of teens who participated in the study said they had consumed cannabis in the past year, and more than one-quarter reported consuming it in the past 28 days.
Don’t miss out on the top cannabis stories of the day. Click here to sign up for our daily insider newsletter.
The study revealed 22% of the teens had a preferred cannabis brand with which they interacted online, and those respondents were eight times more likely to have consumed marijuana in the past month.
This indicates that interacting with marijuana marketing on social media significantly raises the chances of cannabis consumption among teenagers.
The promotions shouldn't make it to the eyes of children who can't buy or use non-medical marijuana, said Megan Moreno, M.D., a professor of pediatrics at the University of Wisconsin School of Medicine and Public Health and co-author of the study, according to Green Rush Daily.
Other studies exist that show marijuana consumption at a young age, especially during important brain developments like puberty, can negatively affects cognitive performance, the publication said.
See more from Benzinga
- Green Growth Brands Reports 271% Higher Quarterly CBD Revenue
- Canopy Rivers Portfolio Company Obtains Health Canada's Approval For Oil Sales
- Tilray Backs First Human Study On Medical Marijuana Used For Breast Cancer Drug Side Effects
© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.